Literature DB >> 3440754

Cytochrome P-450 localization in normal human adult and foetal liver by immunocytochemistry using a monoclonal antibody against human cytochrome P-450.

G I Murray1, T S Barnes, H F Sewell, S W Ewen, W T Melvin, P M Shaw, J Fowler, M D Burke.   

Abstract

Immunocytochemical studies with a monoclonal antibody (MAb-HL3), which recognises a major isozyme of human hepatic cytochrome P-450, have demonstrated this cytochrome in both cryostat and formalin-fixed paraffin-embedded sections of normal human adult liver. Prior trypsin digestion of the formalin-fixed sections prevented staining. There was a zonal distribution of immunoreactive cytochrome P-450, with localization predominantly in the hepatocytes of zone 3 of the hepatic acinus (the centrilobular region). Cytochrome P-450 was also demonstrated in foetal liver, but all foetal hepatocytes contained immunoreactive cytochrome P-450 and there was no zonal distribution of the protein. The biliary epithelium of adult liver contained a small amount of immunoreactive cytochrome P-450 whereas there was no immunoreactivity in the epithelium of foetal bile ducts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440754     DOI: 10.1007/BF01687361

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  18 in total

1.  Perinatal development of the metabolic zonation of hamster liver parenchyma.

Authors:  N Katz; H F Teutsch; K Jungermann; D Sasse
Journal:  FEBS Lett       Date:  1976-10-15       Impact factor: 4.124

2.  Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase.

Authors:  P H Beaune; D R Umbenhauer; R W Bork; R S Lloyd; F P Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

Review 4.  Drug hepatotoxicity.

Authors:  J A Timbrell
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

5.  Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P450, compared with three further P450-isoenzymes, NADPH P450-reductase, glutathione transferases and microsomal epoxide hydrolase.

Authors:  C R Wolf; E Moll; T Friedberg; F Oesch; A Buchmann; W D Kuhlmann; H W Kunz
Journal:  Carcinogenesis       Date:  1984-08       Impact factor: 4.944

6.  Immunochemical examinations of cytochrome P-450 in various tissues of human fetuses using antibodies to human fetal cytochrome P-450, P-450 HFLa.

Authors:  M Kitada; T Kamataki; K Itahashi; T Rikihisa; R Kato; Y Kanakubo
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

Review 7.  Functional hepatocellular heterogeneity.

Authors:  K Jungermann; N Katz
Journal:  Hepatology       Date:  1982 May-Jun       Impact factor: 17.425

Review 8.  Cytochrome P-450: a pharmacological necessity or a biochemical curiosity?

Authors:  M D Burke
Journal:  Biochem Pharmacol       Date:  1981-02-01       Impact factor: 5.858

9.  Identification of an inducible form of cytochrome P-450 in human liver.

Authors:  P B Watkins; S A Wrighton; P Maurel; E G Schuetz; G Mendez-Picon; G A Parker; P S Guzelian
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Immunohistochemical localization of cytochrome P-450a in liver sections from untreated rats and rats treated with phenobarbital or 3-methylcholanthrene.

Authors:  D E Moody; L A Taylor; E A Smuckler; W Levin; P E Thomas
Journal:  Drug Metab Dispos       Date:  1983 Jul-Aug       Impact factor: 3.922

View more
  6 in total

1.  Peri- and postnatal changes in reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase content in hepatocytes of rats.

Authors:  J Watanabe; Y Asaka; S Kanamura
Journal:  Histochem J       Date:  1996-07

2.  Differences in adult and foetal human cytochrome P-450 forms recognized by monoclonal antibodies with specificity for the P450III family.

Authors:  T S Barnes; M D Burke; W T Melvin
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.

Authors:  Hamid Zia; Graeme I Murray; Carrie A Vyhlidal; J Steven Leeder; Ahmed E Anwar; Marilyn M Bui; Atif A Ahmed
Journal:  Int J Exp Pathol       Date:  2015-02-09       Impact factor: 1.925

4.  Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.

Authors:  R A McKinnon; W M Burgess; P M Hall; S J Roberts-Thomson; F J Gonzalez; M E McManus
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

5.  Expression of cytochrome P450IA in breast cancer.

Authors:  G I Murray; C O Foster; T S Barnes; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

6.  Cytochrome P450 CYP3A in human renal cell cancer.

Authors:  G I Murray; M C McFadyen; R T Mitchell; Y L Cheung; A C Kerr; W T Melvin
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.